Purdue Pharma owners strike new $6.5 billion deal in opioid case
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...
Sacklers, Purdue Pharma reach $7.4 billion settlement in opioid lawsuits
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve ...
Texas, other states reach $7.4 billion deal with Purdue Pharma over opioids crisis
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement with Texas and 14 other states to ...
Sackler, Purdue Pharma $7 Billion Lawsuit: Who's Entitled to Payment
The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma ...
Purdue Pharma, Sacklers Reach $7.4 Billion National Opioid Settlement
NEW YORK (Reuters) -Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve ...
Purdue Pharma and Owners to Pay $7.4 Billion in Settlement of Lawsuits Over the Toll of OxyContin
Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...
Texas one of 15 states to reach $7.4 billion opioid settlement with Purdue Pharma
Texas and 14 other states have secured a $7.4 billion settlement from the Sackler family and their company, Purdue Pharma, ...
FiercePharma1d
Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...
Pennsylvania to receive $212M from Purdue Pharma, Sackler family over opioids
The Commonwealth of Pennsylvania is set to receive as much as $212 million of a $7.4 billion settlement from Purdue Pharma ...
Purdue Pharma’s Sacklers Agree to New $6.5 Billion Deal for Opioid Lawsuits
The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.